search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
ANTI-POLLUTION 83


TABLE 3: EFFECT OF H-EPS ON ROS PRODUCTION. EFFECT WAS STUDIED IN KERATINOCYTES AND IN THE POLLUTION MODEL


Mitochondrial membrane potential


UFA per 104


cells


Control (vehicle)


H-EPS


Control (UPM)


UPM + H-EPS


2017 ± 109


1093 ± 180


2560 ± 342


1923 ± 299


% Change Reference -45,8% p<0,01 Reference -24,9% p<0,01


Aldrich) staining. Immunostaining was also performed to determine quantity of involucrin and corneodesmosin.


S. epidermidis growth S. epidermidis were seeded at 4x105 CFU/mL and cultivated with increasing concentrations of H-EPS. Bacteria were then incubated at 37°C for 24 hours. Growth was monitored using a plate reader (Cytation5, BioTEK) using optical density at 600 nm.


Sphingomyelin gene expression S. epidermidis was seeded in 12-well plates (Falcon) and cultivated with H-EPS or its control. Bacteria were then incubated at 37°C for 24 hours. RNA was extracted using a commercial RNA extraction kit (Maxwell) and quantified Nanodrop. cDNA was prepared using iScript cDNA Synthesis kit (Biorad, USA) and 100 ng of RNA. Gene expression was assessed using


SYBRGreen (Biorad, USA) and CFX technology (Biorad, USA). Fold-change of gene expression was calculated using ΔΔCt method


Ceramide quantification Keratinocytes (HaCaTs) were treated with H-EPS or co-cultured with S. epidermidis. Cell lysates and supernatants were used to quantify total amount of ceramides using human ceramide (CER) Elisa kit (Mybiosource).


Clinical evaluation Two independent studies were conducted: one in France (Paris area) and one in China (Guangzhou). The first study was conducted in Paris area on 54 volunteers that applied either a serum containing 3% H-EPS (27 volunteers) or a placebo (27 volunteers) on their face twice a day for two months. Hydration, skin roughness, radiance and firmness were measured after one month and two months. The second study was performed in


Guangzhou on 127 volunteers that applied a sheet mask containing 3% H-EPS twice daily for two weeks. Skin tone and rejuvenation were evaluated at 15 minutes and two weeks, using a self-assessment form.


Statistical analysis For in vitro assays, one-way analysis of variance (ANOVA) was used to determine whether there


www.personalcaremagazine.com UPM UPM + H-EPS Control H-EPS


Figure 2: Effect of UPM and/or H-EPS in skin equivalent models


was any significant difference between the means of two or more independent groups. Difference between two means with similar variances was performed with Student’s t test. A p-value p<0.05 or p<0.01 were considered statistically significant. For clinical studies, statistical analysis were


performed using Student or Wilcoxon test; two tailed, paired series. For the self-assessment study, a Chi-squared test was performed. A p-value p<0.05 or p<0.01 were considered statistically significant.


Results Mitochondrial activity Since studies have shown that pollution disrupts mitochondrial metabolism [2-6], we wanted to identify an active ingredient that could fight against pollution. We therefore established an in vitro pollution model for keratinocytes and studied the effect of UPM in the following parameters: mitochondrial membrane potential; ATP production and mitochondrial oxygen (O2) consumption rates (respiration). UPM inhibited all these parameters validating


our protocol (Table 1). We then tested the effect of H-EPS in mitochondrial metabolism both in basal conditions and the in vitro pollution model. H-EPS was able to induce mitochondrial parameters in basal conditions and to restore all three mitochondria parameters studied, making H-EPS a good candidate to fight pollution in keratinocytes (Table 2).


ROS & NRF2 ROS are a by-product of the mitochondrial respiratory chain. Because H-EPS induced mitochondrial activity in keratinocytes, we wanted to study its effect on ROS. Keratinocytes were treated with H-EPS and ROS were quantified. Despite the activation of mitochondrial metabolism, H-EPS inhibited ROS production basally (Table 3). Furthermore, H-EPS was also able to reduce ROS generated by UPM (Table 3). The NRF2 pathway is involved in cellular


detoxification. NRF2 translocation to the nuclei activates HMOX and NQO-1 enzymes that scavenge intracellular ROS. NRF2 is activated by both H-EPS and UPM (Figure 1A). H-EPS induced moderate NRF2 activation (36%- 41%) that remained stable over 24 hours. NRF2 activation was significantly higher in


UPM treated keratinocytes and increased over 24 hours to maximum of 401% relative to untreated controls (Figure 1B). We conclude that NRF2 activation by H-EPS allows keratinocytes to reduce ROS production. In pollution treated cells, NRF2 activation may


be explained by a protective defence mechanism. Because ROS levels continue growing, NRF2 remained activated. Altogether these data suggest that H-EPS reduces ROS production by efficiently activating NRF2.


Skin structure We then set up an equivalent skin model treated


May 2026 PERSONAL CARE MAGAZINE


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100